Related Experiment Video
Updated: Oct 25, 2025

08:58
Label-Free Identification of Lymphocyte Subtypes Using Three-Dimensional Quantitative Phase Imaging and Machine Learning
Published on: November 19, 2018
12.7K
A Machine Learning Tool Using Digital Microscopy (Morphogo) for the Identification of Abnormal Lymphocytes in the
Gusheng Tang1, Xinyan Fu2, Zhen Wang3
1Department of Hematology, Changhai Hospital, Shanghai, China.
Acta Cytologica
|August 5, 2021
Summary
A new machine learning system, Morphogo, accurately distinguishes abnormal lymphocytes from normal ones in bone marrow digital images, offering a faster, more reliable diagnostic tool for hematological diseases.
Area of Science:
- Computational pathology
- Hematology
- Artificial Intelligence
Background:
- Manual bone marrow smear analysis is labor-intensive and prone to interobserver variability.
- Distinguishing abnormal from normal lymphocytes in bone marrow morphology is challenging.
- Digital pathology and machine learning offer potential for automated, accurate cell classification.
Purpose of the Study:
- To develop and validate a machine learning system (Morphogo) for discriminating abnormal from normal lymphocytes in digital bone marrow images.
- To assess the system's accuracy in identifying lymphoma cells in bone marrow samples.
Main Methods:
- Developed a machine learning algorithm incorporating color, texture, and geometrical features for lymphocyte image analysis.
- Trained the algorithm on 15,353 bone marrow cell images from 43 confirmed lymphoma cases.
- Validated the system on images from 10 additional cases, comparing results with pathologist diagnoses.
Main Results:
- The Morphogo system achieved a 99.04% positive predictive value for identifying reactive/normal versus abnormal lymphoid cells.
- The AI-based system demonstrated high accuracy in classifying lymphocyte categories based on digital image analysis.
Conclusions:
- Digital pathology combined with machine learning provides a feasible approach for automated lymphoma cell diagnosis in bone marrow.
- The Morphogo system shows promise as a robust and efficient screening tool for hematological diseases.
- Future improvements may enable further subclassification of specific lymphoma subtypes.

